Merck KGaA (0O14)
LSE
135.50
-4.35 (-3.11%)
Closed
Oct 8, 2026
Day's Range
135.35138.35
52 wk Range
100.70148.50
Financial Statements - 0O14 - Merck KGaA
Revenue
21.10B▼ 0.3%
Net Income
2.61B▼ 6.1%Net Margin 12.4%
EBITDA
6.25B▼ 1.7%
Free Cash Flow
1.97B▼ 17.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 21.10B | 21.15B | 20.99B | 22.23B | 19.68B | 17.53B |
| Cost of Goods | 8.75B | 8.67B | 8.60B | 8.52B | 7.35B | 6.83B |
| Gross Profit | 12.34B | 12.48B | 12.39B | 13.70B | 12.33B | 10.69B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 3.65B | 4.01B | 3.57B | 4.75B | 4.20B | 2.81B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 3.30B | 3.53B | 3.48B | 4.28B | 3.92B | 2.63B |
| Income Tax | 693M | 751M | 650M | 948M | 859M | 637M |
| Net Income | 2.61B | 2.78B | 2.83B | 3.33B | 3.06B | 1.99B |
| EPS Basic | 6 | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| EPS Diluted | 6 | 6.39 | 6.49 | 7.65 | 7.03 | 4.57 |
| Basic Shares Outstanding | 434.77M | 434.77M | 434.77M | 434.77M | 434.77M | 434.77M |
| Diluted Shares Outstanding | 434.77M | 434.77M | 434.77M | 434.77M | 434.77M | 434.77M |
| Ebit | 3.69B | 3.82B | 3.80B | 4.52B | 4.19B | 3.01B |
| Ebitda | 6.25B | 6.36B | 5.67B | 6.78B | 5.98B | 4.72B |
| Net Income Continuous Operations | 2.61B | 2.78B | 2.83B | 3.33B | 3.06B | 1.99B |
| Minority Interests | -7M | -9M | -10M | -14M | -10M | -7M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
